M. Keane

Exosomes Contribution to the Establishment of the Pre-Metastatic Niche Through the Induction of the Epithelial-to-Mesenchymal Transition in Lymphangioleiomyomatosis (LAM): Implication of the Complement Cascade
20230 citationsauthor #7
Presentation, Mode of Diagnosis and Management of Pulmonary Alveolar Proteinosis Syndrome in an Irish Population
20230 citationsauthor #9
Abstract 1230: The pre-metastatic niche establishment through the induction of the epithelial-to-mesenchymal transition by circulating exosomes in lymphangioleiomyomatosis (LAM): implication of the complement cascade
20230 citationsauthor #8
Diagnostic Utility of Quantitative 3D HRCT Analysis to in Diffuse Cystic Lung Diseases
20230 citationsauthor #8
Combined autologous blood patch-immediate patient rollover does not reduce the pneumothorax or chest drain rate following CT-guided lung biopsy compared to immediate patient rollover alone.
20235 citationsauthor #8
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
202353 citationsauthor #22
Genetic and geographic influence on phenotypic variation in European sarcoidosis patients
202310 citationsauthor #21
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CTPFAV) in idiopathic pulmonary fibrosis
20239 citationsauthor #15
Abstract 958: Exosomes from EGFR-mutated adenocarcinoma induce a hybrid EMT and MMP9-dependant tumour invasion
20220 citationsauthor #7
Promising Idiopathic Pulmonary Fibrosis Therapeutics.
20220 citationsauthor #3
Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery
202238 citationsauthor #5
Presentation, Mode of Diagnosis and Prevalence of Lymphangioleiomyomatosis in an Irish Population
20220 citationsauthor #7
Exosomes from EGFR-mutated adenocarcinoma induce a partial/hybrid EMT
20220 citationsauthor #7
A National Rare Lung Disease Clinic: Patient Characteristics and Lessons Learned
20220 citationsauthor #4
Contemporary Concise Review 2021: Interstitial lung disease
202212 citationsauthor #2
Thinking Outside of the Lungs; Screening for Extrapulmonary Features of Sarcoidosis
20220 citationsauthor #5
D-Dimers as a Predictor of PE in Individuals Undergoing CTPA
20220 citationsauthor #7
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Partial/Hybrid EMT and an MMP9-Dependant Tumour Invasion
20220 citationsauthor #7
Vaping-Associated Lung Injury: A Review
202226 citationsauthor #4
A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease
20220 citationsauthor #5
Extended D-dimer cut-offs and machine learning for ruling out pulmonary embolism in individuals undergoing computed tomography pulmonary angiography
20220 citationsauthor #11
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
202213 citationsauthor #6
Pulmonary renal syndrome: a clinical review
202227 citationsauthor #5
Atypical cause of bronchial cut-off sign
20211 citationsauthor #6
Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency
20210 citationsauthor #4
Patient Characteristics and Mode of Diagnosis of Lymphangioleiomyomatosis in an Irish Population
20210 citationsauthor #9
Unclassifiable interstitial lung disease on HRCT: aggressive progressive disease with macrocystic lung destruction.
20210 citationsauthor #9
Autoimmune pulmonary alveolar proteinosis: a discrepancy between symptoms and CT findings.
20217 citationsauthor #6
Exosomes: a new perspective in EGFR-mutated lung cancer
202133 citationsauthor #4
Provision of essential bronchoscopy during COVID‐19 pandemic
20210 citationsauthor #3
The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
20210 citationsauthor #4
Bedwetting
20210 citationsauthor #44
The effect of the COVID-19 pandemic on CTPA use in an academic medical centre
20210 citationsauthor #7
Methionine supplementation: potential for improving alveolar macrophage function through reverse cholesterol transport?
20215 citationsauthor #4
Plasma cell-free DNA EGFR mutation detection in patients with non-small cell lung carcinoma using two commercially available platforms the COBAS® and Idylla™
20210 citationsauthor #8
The impact of COVID-19 on clinical education of internal medicine trainees
202010 citationsauthor #5
A 34-Year-Old Man With a Chylothorax and Bony Pain.
20202 citationsauthor #6
Macrophage Inflammatory Protein
202022 citationsauthor #1
Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state
20209 citationsauthor #14
Recommended Reading from the University College Dublin and St. Vincent's University Hospital Pulmonary Research Fellows.
20200 citationsauthor #4
Prevalence of comorbid asthma in COVID-19 patients
202038 citationsauthor #6
Sequential FDG-PET in the management of multiorgan sarcoidosis
20200 citationsauthor #2
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI
20208 citationsauthor #16
Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury
20202 citationsauthor #2
The Impact of COVID-19 on Pulmonary Fellowship Training in an Irish Setting
20202 citationsauthor #3
Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
202062 citationsauthor #9
Vaping-associated lung injury
20208 citationsauthor #5
CXCR3A promotes the secretion of the anti-fibrotic decoy receptor sIL-13Rα2 by pulmonary fibroblasts.
202010 citationsauthor #6
Ballistic Limit Shot Dependency Testing in Composite Materials
20202 citationsauthor #1
Exosomes Form EGFR-Mutated Adenocarcinoma Induce Tumour Invasion
20191 citationsauthor #8
Fibrocyte-Derived Exosomes Contain Profibrotic miRNAs Consistent with Serum miRNAs from Patients with Idiopathic Pulmonary Fibrosis
20190 citationsauthor #4
The Fibrosis Burden of Systemic Sclerosis
20190 citationsauthor #1
Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
201985 citationsauthor #89
CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.
20196 citationsauthor #11
The Role of Immunity and Inflammation in IPF Pathogenesis
201810 citationsauthor #2
Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
201829 citationsauthor #6
Phenotypes of organ involvement in sarcoidosis
2018191 citationsauthor #30
Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT.
201766 citationsauthor #12
Smoking-Related Interstitial Fibrosis: Evidence of Radiologic Regression with Advancing Age and Smoking Cessation
201711 citationsauthor #8
Buying and Selling Long Ago
20170 citationsauthor #13
Altered Expression of Bone Morphogenetic Protein Accessory Proteins in Murine and Human Pulmonary Fibrosis.
201632 citationsauthor #7
Adalimumab for refractory pulmonary sarcoidosis
201616 citationsauthor #3
Bronchitis, Bronchiectasis
20161 citationsauthor #2
Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.
201673 citationsauthor #2
Galectin-3: Distant Biomarker or Relevant Target?
20162 citationsauthor #1
Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis.
20164 citationsauthor #8
Toll-like receptor 3 (TLR3) L412F single nucleotide polymorphism promotes disease progression in idiopathic pulmonary fibrosis (IPF): implications for viral and bacterial infection in TLR3-defective patients.
20160 citationsauthor #6
A rare cause of cystic lung disease – Birt-Hogg-Dubé syndrome
20162 citationsauthor #3
Welcome to ICLAF 2016 Dublin, Ireland
20160 citationsauthor #2
Serum exosomes from IPF patients contain miR-125b, which is correlated to severity of disease progression.
20160 citationsauthor #11
Idiopathic Pulmonary Fibrosis With Emphysema: Evidence of Synergy Among Emphysema and Idiopathic Pulmonary Fibrosis in Smokers
201531 citationsauthor #4
CXCL9 Regulates TGF-β1–Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells
201536 citationsauthor #14
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
20150 citationsauthor #9
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
201514 citationsauthor #9
The Modulation of Pulmonary Fibrosis by IL-13 Rα 2 1 2
20150 citationsauthor #15
Predicting progression of RA-ILD using anti-CCP
20151 citationsauthor #4
Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers.
201523 citationsauthor #8
Modulation of pulmonary fibrosis by IL-13Rα2.
201540 citationsauthor #13
The Influence of Smoking Status on Circulating Fibrocytes in Health and in Smoking-Related Fibrogenic Lung Disease States.
20140 citationsauthor #12
Serum exosomes from IPF patients display a fibrotic miRNA profile and induce collagen production in vitro.
20140 citationsauthor #11
Fibrosis in emphysema: Radiologically occult but histologically prevalent process proportionate to smoking burden
20140 citationsauthor #9
CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
201410 citationsauthor #11
The Regulation of the CXCR3 Receptor in Primary Lung Fibroblasts
20140 citationsauthor #7
Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer
201464 citationsauthor #8
The myofibroblast in pulmonary fibrosis displays distinct functional characteristics, depending on its source of origin
20142 citationsauthor #6
The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
2013149 citationsauthor #5
Sarcoidosis, alveolar β-actin and pulmonary fibrosis.
20138 citationsauthor #6
Metastatic chordoma detected by endobronchial ultrasound-guided transbronchial needle aspiration.
20133 citationsauthor #6
Translational Science Sarcoidosis, alveolar b-actin and pulmonary fibrosis
20130 citationsauthor #6
Sarcoidosis , alveolar b-actin and pulmonary fibrosis
20130 citationsauthor #6
The Anti Fibrotic Effects Of Mesenchymal Stem Cells Are Mediated In Part By IL-13R±2
20121 citationsauthor #8
A Cost Effectiveness Comparison Between Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy In A National Lung Cancer Centre
20121 citationsauthor #6
Rapid needle-out patient-rollover time after percutaneous CT-guided transthoracic biopsy of lung nodules: effect on pneumothorax rate.
201288 citationsauthor #7
Overexpression Of IL-13Rα2 Inhibits The Fibrotic Response
20120 citationsauthor #8
CXCL9 Abrogates TGF-²1 Induced Epithelial To Mesenchymal Transition Via Smad7 In Pulmonary Epithelial Cells
20120 citationsauthor #8
Bronchopleural cutaneous fistula after pulmonary radiofrequency ablation: treatment with low-adherent paraffin gauze dressing.
20125 citationsauthor #6
Poststernotomy lymphadenopathy: prevalence, size, and location on chest CT.
20121 citationsauthor #6
A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease
201154 citationsauthor #6
Mechanisms Of The Inhibitory Effects Of CXCL9 On TGF-Beta Induced Epithelial To Mesenchymal Transition
20110 citationsauthor #7
Physiological and pathological angiogenesis in the adult pulmonary circulation.
201115 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT